Profile data is unavailable for this security.
About the company
Sawai Group Holdings Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical and over-the-counter drugs. The Company operates in two segments. The Japan segment is engaged in medical and healthcare-related businesses such as manufacture and sale of pharmaceuticals and medical devices, as well as various related businesses. The America segment is engaged in the sale of manufactured pharmaceutical products to wholesale stores in America. The company is also engaged in the research and development of pharmaceutical products.
- Revenue in JPY (TTM)189.02bn
- Net income in JPY2.17bn
- Incorporated2021
- Employees3.31k
- LocationSawai Group Holdings Co Ltd5-2-30, Miyahara, Yodogawa-kuOSAKA-SHI 532-0003JapanJPN
- Phone+81 661055818
- Websitehttps://www.sawaigroup.holdings
More ▼
Mergers & acquisitions
| Acquired company | 4887:TYO since announced | Transaction value |
|---|---|---|
| Frontact | -7.69% | -- |
Data delayed at least 15 minutes, as of Jul 18 2025 07:30 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Towa Pharmaceutical Co Ltd | 259.59bn | 18.99bn | 164.85bn | 4.79k | 8.30 | 0.9179 | 4.22 | 0.635 | 385.70 | 385.70 | 5,273.63 | 3,486.39 | 0.5759 | 1.57 | 3.69 | 54,217,630.00 | 4.21 | 3.89 | 5.18 | 5.07 | 36.49 | 37.81 | 7.31 | 6.61 | 1.58 | -- | 0.5737 | 21.52 | 13.89 | 18.65 | 17.39 | 5.53 | 46.23 | 9.73 |
| Kaken Pharmaceutical Co Ltd | 94.04bn | 13.95bn | 169.89bn | 1.13k | 10.34 | 0.9684 | 10.30 | 1.81 | 372.31 | 372.31 | 2,464.10 | 3,974.44 | 0.5195 | 1.96 | 4.23 | 83,512,430.00 | 7.70 | 5.99 | 8.92 | 6.87 | 62.25 | 56.17 | 14.83 | 12.91 | 3.04 | -- | 0.0246 | 59.58 | 30.52 | 1.05 | 73.77 | -6.36 | 14.81 | 0.00 |
| Torii Pharmaceutical Co Ltd | 61.66bn | 5.56bn | 182.02bn | 592.00 | 31.98 | 1.47 | 30.56 | 2.95 | 197.61 | 197.61 | 2,193.40 | 4,311.56 | 0.4573 | 2.46 | 2.25 | 104,152,000.00 | 4.12 | 3.01 | 4.59 | 3.36 | 44.39 | 47.87 | 9.01 | 7.91 | 5.15 | -- | 0.00 | 61.32 | 10.59 | 7.04 | 22.41 | -28.70 | -19.90 | 20.11 |
| Kissei Pharmaceutical Co Ltd | 88.33bn | 11.96bn | 198.04bn | 1.78k | 15.49 | 0.8715 | 11.94 | 2.24 | 274.64 | 274.64 | 2,024.90 | 4,882.69 | 0.3498 | 1.73 | 3.04 | 49,679,420.00 | 4.74 | 4.26 | 5.11 | 4.60 | 49.89 | 48.59 | 13.56 | 14.30 | 4.95 | -- | 0.0075 | 32.41 | 16.87 | 6.91 | 7.18 | 33.54 | 31.04 | 13.97 |
| Nippon Shinyaku Co Ltd | 160.23bn | 32.56bn | 219.75bn | 2.24k | 6.47 | 0.8532 | 5.70 | 1.37 | 483.40 | 483.40 | 2,379.02 | 3,666.27 | 0.5858 | 1.25 | 3.63 | 71,436,470.00 | 11.90 | 10.89 | 13.60 | 12.74 | 68.10 | 63.93 | 20.32 | 17.67 | 3.54 | -- | 0.0109 | 30.58 | 8.08 | 6.56 | 25.94 | 14.06 | 80.48 | 7.59 |
| Sawai Group Holdings Co Ltd | 189.02bn | 2.17bn | 227.13bn | 3.31k | 211.15 | 1.31 | 13.04 | 1.20 | 9.32 | 82.53 | 1,518.81 | 1,505.86 | 0.5132 | 1.26 | 3.56 | 57,106,950.00 | 0.590 | -0.2327 | 0.8126 | -0.3187 | 29.81 | 32.95 | 1.15 | -0.475 | 0.8847 | 4.56 | 0.3536 | 191.65 | 6.88 | 0.7009 | -87.38 | -35.38 | 8.65 | 4.11 |
| Tsumura & Co | 181.09bn | 32.43bn | 278.48bn | 4.27k | 8.49 | 0.9143 | 6.09 | 1.54 | 427.12 | 427.12 | 2,385.35 | 3,968.06 | 0.4058 | 0.72 | 2.73 | 42,390,680.00 | 7.74 | 5.53 | 9.75 | 6.85 | 50.02 | 49.39 | 19.06 | 14.50 | 2.62 | -- | 0.1766 | 31.65 | 20.05 | 8.00 | 94.10 | 18.69 | 23.07 | 16.27 |
| Hisamitsu Pharmaceutical Co Inc | 154.86bn | 19.53bn | 302.09bn | 2.80k | 15.06 | 1.09 | 11.37 | 1.95 | 266.82 | 266.82 | 2,114.93 | 3,703.39 | 0.4597 | 2.64 | 3.48 | 55,327,260.00 | 5.93 | 4.34 | 7.04 | 4.99 | 59.20 | 57.83 | 12.89 | 10.32 | 3.75 | -- | 0.0096 | 50.29 | 10.09 | 2.04 | 55.76 | 3.08 | 29.89 | 0.7127 |
Data as of Jul 18 2025. Currency figures normalised to Sawai Group Holdings Co Ltd's reporting currency: Japanese Yen JPY
34.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 30 Apr 2025 | 8.81m | 6.71% |
| Nomura Asset Management Co., Ltd.as of 14 Mar 2025 | 8.65m | 6.58% |
| Silchester International Investors LLPas of 17 Mar 2025 | 7.52m | 5.72% |
| FIL Investments (Japan) Ltd.as of 31 May 2025 | 4.44m | 3.37% |
| The Vanguard Group, Inc.as of 02 Jul 2025 | 3.99m | 3.03% |
| JPMorgan Asset Management (Japan) Ltd.as of 31 Dec 2024 | 3.36m | 2.55% |
| Goldman Sachs Asset Management LPas of 10 Jul 2025 | 2.54m | 1.93% |
| Nikko Asset Management Co., Ltd.as of 15 Oct 2024 | 2.20m | 1.67% |
| Daiwa Asset Management Co. Ltd.as of 30 May 2025 | 1.99m | 1.52% |
| Dimensional Fund Advisors LPas of 04 Jul 2025 | 1.96m | 1.49% |
More ▼
Data from 31 Mar 2025 - 10 Jul 2025Source: FactSet Research Systems Inc.
